Japanske og Kinesiske patienter (se afsnit 4. 3 Kontraindikationer og 5. 2 Farmakokinetiske egenskaber).
The 40 mg dose is contraindicated in Japanese and Chinese patients (see sections 4.3 Contraindications and 5.2 Pharmacokinetic properties).